Textbook of Clinical Metal Toxicology (10th ed.)
Globally launched clinical trials like the European study DISCOVERY showed that antiviral drugs (remdesivir, lopinavir and ritonavir in combination, ritonavir given with or without interferon beta and hydroxychloroquine) are unable to efficiently attack COVID-19 progression (Ader et al., 2022)
However, an important shift is occurring in clinical practice: we are recognizing patients with socalled lean MASLD and questioning whether our traditional therapeutic frameworks adequately address the full spectrum of disease
We use proven nutrition advice to promote sustainable behavioral change that will follow you for life
Great to collaborate with former, current, and future colleagues: Lucy West Amanda Vest Luke Laffin Harsh Patolia Brittany Chapman
Sixth, the cohort was predominantly male (85.2%), from a single tertiary care centre with MASLD and ALD as predominant etiologies